Explained herein are pharmaceutical packaging programs which stop oxidative degradation of morphine, hydromorphone, promethazine as well as other oxygen-sensitive medicine, such systems which include a syringe by having an oxygen permeable suggestion cap, a hermetically sealed oxygen barrier blister packaging with very very low permeability to oxyg